Sivagurunathan S.
- Country
- Germany
- Department
- n/a
Research Overview
- A Phase IIb Randomized Study to Evaluate the Efficacy and Safety of AZD0292 in Patients with Bronchiectasis and Chronic Pseudomonas aeruginosa Colonization
- Efficacy and Safety of Early Depemokimab Initiation as Add-on Therapy in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
- Phase 3 Study of GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma
Data & Insights
Has run more than one trial at 304 of 674 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating complex respiratory conditions, with particular emphasis on cystic fibrosis and its associated complications including pancreatic exocrine insufficiency. Their work extends to evaluating innovative therapeutic formulations for improved patient outcomes.
- Cystic Fibrosis Treatment Innovations
- Pancreatic Enzyme Replacement Therapy
- Bronchiectasis Management
Pulmonary Infections
The investigator focuses on treating challenging respiratory infections, particularly nontuberculous mycobacterial lung infections and Pseudomonas aeruginosa in bronchiectasis. Their expertise includes evaluating novel inhalation therapies and antimicrobial treatments.
- Mycobacterium Avium Complex Treatment
- Inhaled Antibiotic Therapies
- Respiratory Infection Control
Chronic Airways Disease
Specializing in the treatment of chronic respiratory conditions, the investigator works with uncontrolled asthma and chronic obstructive pulmonary disease. Their focus includes evaluating combination therapies and novel therapeutic approaches for airways disease.
- Asthma Control Strategies
- COPD Management
- Airway Function Assessment
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.